| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.468 | 13.109 | 11.518 | 17.018 | 3.375 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 9.468 | 13.109 | 11.518 | 17.018 | 3.375 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 6.430 | 7.025 | 5.371 | 11.833 | 3.595 | 4.088 | 255 | 10 | 10 | 0 |
| Gross Profit/Loss - EUR | 3.038 | 6.084 | 6.148 | 5.184 | -220 | -4.088 | -255 | -10 | -10 | 0 |
| Net Profit/Loss - EUR | 2.753 | 5.658 | 5.802 | 4.674 | -321 | -4.088 | -255 | -10 | -10 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Domar Medclinical Services Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.921 | 5.843 | 3.324 | 589 | 388 | 195 | 10 | 0 | 0 | 0 |
| Current Assets | 859 | 1.104 | 3.474 | 4.480 | 5.392 | 43 | 25 | 0 | 0 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 684 | 677 | 0 | 41 | 1.045 | 0 | 0 | 0 | 0 | 0 |
| Cash | 175 | 427 | 3.474 | 4.440 | 4.347 | 43 | 25 | 0 | 0 | 0 |
| Shareholders Funds | -6.360 | -637 | 5.176 | 5.027 | 4.608 | -437 | -682 | -694 | -692 | -688 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.140 | 7.584 | 1.623 | 42 | 1.171 | 676 | 718 | 694 | 692 | 688 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Domar Medclinical Services Srl